Gene drug ‘only hope’ for Turkish child, but costs millions
21 November 2022, 08:15
Zolgensma may stop five-year-old Yusuf Polat's spinal muscular atrophy from progressing, but it costs $2.1m.
Zolgensma may stop five-year-old Yusuf Polat's spinal muscular atrophy from progressing, but it costs $2.1m.
Comments (0)
Do you like the page?
Would you like to share the page with your friends?